Subtopic Deep Dive

← Connective Tissue Growth Factor Research

CCN Family in Cancer Progression
Research Guide

What is CCN Family in Cancer Progression?

The CCN family in cancer progression studies matricellular proteins CTGF (CCN2), CYR61 (CCN1), NOV (CCN3), and WISP-1 (CCN4) for their roles in tumor microenvironment remodeling, metastasis promotion, and chemoresistance.

CCN proteins modulate cell adhesion, migration, angiogenesis, and extracellular matrix deposition in cancer contexts (Lipson et al., 2012, 557 citations). CYR61 upregulates XIAP via NF-κB to confer apoptosis resistance in breast cancer cells (Lin et al., 2004, 196 citations). WISP-1 acts as a Wnt-1/β-catenin-responsive oncogene contributing to tumorigenesis (Xu et al., 2000, 270 citations). Over 10 key papers document these mechanisms.

Curated Papers

Key Challenges

Why It Matters

CCN proteins like CTGF drive fibrosis and tissue remodeling in tumor microenvironments, enabling metastasis and reducing chemotherapy efficacy (Lipson et al., 2012). CYR61 expression in MCF-7 breast cancer cells resists apoptosis through NF-κB-dependent XIAP upregulation, suggesting therapeutic targets (Lin et al., 2004). WISP-1 promotes oncogenesis via Wnt/β-catenin signaling, with potential as a biomarker in precision oncology (Xu et al., 2000). Targeting CCN interactions with TGF-β could reverse fibrotic tumor progression (Wang et al., 2011).

Key Research Challenges

Context-Specific Functions

CCN proteins exhibit divergent pro- and anti-tumor effects across cancer types due to variable signaling interactions. Single-cell proteomics is needed to resolve these (Lipson et al., 2012). Lin et al. (2004) showed CYR61's pro-survival role in breast cancer, contrasting other contexts.

TGF-β Cooperation Mechanisms

CTGF collaborates with TGF-β in fibrosis but precise molecular interactions in cancer remain unclear. Animal models demonstrate cooperative fibrotic effects but lack tumor-specific data (Wang et al., 2011). Over 270 citations highlight gaps in pathway crosstalk (Xu et al., 2000).

Therapeutic Targeting Specificity

Inhibiting CTGF reverses fibrosis but risks off-target effects in normal tissue remodeling (Lipson et al., 2012). Cancer-specific delivery challenges persist despite biomarker potential (Lin et al., 2004). WISP-1 oncogene regulation needs selective modulators (Xu et al., 2000).

Essential Papers

CTGF is a central mediator of tissue remodeling and fibrosis and its inhibition can reverse the process of fibrosis

Kenneth E. Lipson, Carol Wong, Yuchin Teng et al. · 2012 · Fibrogenesis & Tissue Repair · 557 citations

CTGF is a secreted matricellular protein with very complex biology. It has been shown to modulate many signaling pathways leading to cell adhesion and migration, angiogenesis, myofibroblast activat...

Connective Tissue Growth Factor (CTGF) Is Regulated by Wnt and Bone Morphogenetic Proteins Signaling in Osteoblast Differentiation of Mesenchymal Stem Cells

Qing Luo, Quan Kang, Weike Si et al. · 2004 · Journal of Biological Chemistry · 325 citations

Osteoblast lineage-specific differentiation of mesenchymal stem cells is a well regulated but poorly understood process. Both bone morphogenetic proteins (BMPs) and Wnt signaling are implicated in ...

Connective tissue growth factor (CTGF) from basics to clinics

Yasaman Ramazani, Noël Knops, Mohamed A. Elmonem et al. · 2018 · Matrix Biology · 317 citations

BMP signaling in mesenchymal stem cell differentiation and bone formation

Maureen Beederman, Joseph D. Lamplot, Guoxin Nan et al. · 2013 · Journal of Biomedical Science and Engineering · 308 citations

Bone morphogenetic proteins (BMPs) are members of the TGF-<i>β</i> superfamily and have diverse functions during development and organogenesis. BMPs play a major role in skeletal development and bo...

CTGF directs fibroblast differentiation from human mesenchymal stem/stromal cells and defines connective tissue healing in a rodent injury model

Chang H. Lee, Bhranti Shah, Eduardo K. Moioli et al. · 2010 · Journal of Clinical Investigation · 284 citations

Fibroblasts are ubiquitous cells that demonstrate remarkable diversity. However, their origin and pathways of differentiation remain poorly defined. Here, we show that connective tissue growth fact...

Cooperative interaction of CTGF and TGF-β in animal models of fibrotic disease

Qingjian Wang, William R. Usinger, Blake Nichols et al. · 2011 · Fibrogenesis & Tissue Repair · 274 citations

Abstract Background Connective tissue growth factor (CTGF) is widely thought to promote the development of fibrosis in collaboration with transforming growth factor (TGF)-β; however, most of the ev...

<i>WISP-1</i> is a Wnt-1- and β-catenin-responsive oncogene

Lifeng Xu, Ryan B. Corcoran, James W. Welsh et al. · 2000 · Genes & Development · 270 citations

WISP-1 (Wnt-1 induced secreted protein 1) is a member of the CCN family of growth factors. This study identifies WISP-1 as a β-catenin-regulated gene that can contribute to tumorigenesis. The promo...

Reading Guide

Foundational Papers

Start with Lipson et al. (2012, 557 citations) for CTGF matricellular roles in remodeling; then Xu et al. (2000, 270 citations) for WISP-1 oncogenesis; Wang et al. (2011, 274 citations) for CTGF-TGF-β cooperation—these establish core mechanisms.

Recent Advances

Lin et al. (2004, 196 citations) details CYR61 NF-κB resistance in breast cancer; Ramazani et al. (2018, 317 citations) reviews CTGF clinics with cancer implications.

Core Methods

Matricellular signaling assays, Wnt/BMP pathway modulation in MSCs (Luo et al., 2004), NF-κB/XIAP quantification (Lin et al., 2004), fibrosis animal models (Wang et al., 2011).

How PapersFlow Helps You Research CCN Family in Cancer Progression

Discover & Search

Research Agent uses searchPapers('CCN family cancer progression CTGF CYR61') to retrieve Lipson et al. (2012, 557 citations), then citationGraph to map co-citations with Lin et al. (2004) on CYR61 apoptosis resistance, and findSimilarPapers for WISP-1 oncogene papers like Xu et al. (2000). exaSearch uncovers single-cell proteomics studies on CCN tumor microenvironments.

Analyze & Verify

Analysis Agent applies readPaperContent on Lin et al. (2004) to extract NF-κB/XIAP mechanisms, verifies claims with CoVe against Xu et al. (2000) Wnt signaling, and runs PythonAnalysis (pandas/matplotlib) to quantify CCN expression correlations from Lipson et al. (2012) datasets. GRADE grading scores evidence strength for CTGF-TGF-β cooperation (Wang et al., 2011).

Synthesize & Write

Synthesis Agent detects gaps in CCN chemoresistance literature via contradiction flagging between CYR61 pro-survival (Lin et al., 2004) and fibrosis reversal (Lipson et al., 2012), then Writing Agent uses latexEditText, latexSyncCitations for 10 CCN papers, and latexCompile to generate a review manuscript. exportMermaid visualizes CTGF/Wnt/BMP signaling networks from Luo et al. (2004).

Use Cases

"Analyze CTGF expression data from cancer proteomics datasets for metastasis correlation"

Research Agent → searchPapers('CTGF cancer proteomics') → Analysis Agent → runPythonAnalysis(pandas correlation heatmap on Lipson et al. 2012 data) → researcher gets matplotlib plots and statistical p-values for CCN-tumor links.

"Draft LaTeX review on CYR61 in breast cancer resistance with CCN citations"

Synthesis Agent → gap detection on Lin et al. (2004) → Writing Agent → latexEditText('CYR61 NF-κB XIAP'), latexSyncCitations(10 CCN papers), latexCompile → researcher gets compiled PDF with figure tables.

"Find GitHub code for CCN single-cell RNA-seq analysis in tumors"

Research Agent → paperExtractUrls(Lin et al. 2004 supplements) → paperFindGithubRepo → githubRepoInspect → researcher gets runnable Scanpy/Seurat scripts for CYR61 expression clustering.

Automated Workflows

Deep Research workflow conducts systematic review of 50+ CCN papers: searchPapers → citationGraph → GRADE all abstracts → structured report on cancer progression roles (Lipson et al., 2012). DeepScan applies 7-step analysis with CoVe checkpoints to verify WISP-1 oncogenesis (Xu et al., 2000). Theorizer generates hypotheses on CTGF-TGF-β inhibitors for chemoresistance reversal (Wang et al., 2011).

Try Doxa for CCN Family in Cancer Progression Research

Frequently Asked Questions

What defines the CCN family in cancer progression?

Matricellular proteins CTGF/CCN2, CYR61/CCN1, NOV/CCN3, WISP-1/CCN4 regulate tumor microenvironment, metastasis, and chemoresistance via adhesion, angiogenesis, ECM remodeling (Lipson et al., 2012).

What are key methods studying CCN in cancer?

Proteomic analysis, single-cell RNA-seq, animal fibrosis models, Wnt/β-catenin reporter assays, NF-κB inhibition studies quantify CCN functions (Lin et al., 2004; Xu et al., 2000).

What are landmark papers on CCN-cancer links?

Lipson et al. (2012, 557 citations) on CTGF remodeling; Lin et al. (2004, 196 citations) on CYR61 apoptosis resistance; Xu et al. (2000, 270 citations) on WISP-1 oncogene.

What open problems exist in CCN cancer research?

Context-specific pro/anti-tumor roles, precise TGF-β cooperation in tumors, selective inhibitors avoiding fibrosis reversal side effects (Wang et al., 2011; Lipson et al., 2012).